Статья

Proteomics of diphtheria toxoid vaccines reveals multiple proteins that are immunogenic and may contribute to protection of humans against Corynebacterium diphtheriae

J. Möller, M. Kraner, U. Sonnewald, V. Sangal, H. Tittlbach, J. Winkler, T. Winkler, V. Melnikov, R. Lang, A. Sing, A. Mattos-Guaraldi, A. Burkovski,
2021

Introduced for mass immunization in the 1920s, vaccines against diphtheria are among the oldest and safest vaccines known. The basic principle of their production is the inactivation of purified diphtheria toxin by formaldehyde cross-linking, which converts the potentially fatal toxin in a completely harmless protein aggregate, which is still immunogenic. Since in addition to diphtheria toxin also other proteins may be secreted by Corynebacterium diphtheriae during cultivation, we assumed that diphtheria toxoid might not be the only component present in the vaccine. To address this question, we established a protocol to reverse formaldehyde cross-linking and carried out mass spectrometric analyses. Different secreted, membrane-associated and cytoplasmic proteins of C. diphtheriae were detected in several vaccine preparations from across the world. Based on these results, bioinformatics and Western blot analyses were applied to characterize if these proteins are immunogenic and may therefore support protection against C. diphtheriae. In frame of this study, we could show that the C. diphtheriae toxoid vaccines induce antibodies against different C. diphtheriae proteins and against diphtheria toxin secreted by Corynebacterium ulcerans, an emerging pathogen which is outnumbering C. diphtheriae as cause of diphtheria-like illness in Western Europe. © 2019

Цитирование

Похожие публикации

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • J. Möller
    Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  • M. Kraner
    Lehrstuhl für Biochemie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  • U. Sonnewald
    Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom
  • V. Sangal
    Lehrstuhl für Genetik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  • H. Tittlbach
    Medizinische Klinik 5, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  • J. Winkler
    Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russian Federation
  • T. Winkler
    Institute of Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  • V. Melnikov
    German National Consiliary, Laboratory on Diphtheria. Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Oberschleißheim, Germany
  • R. Lang
    Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil
  • A. Sing
  • A. Mattos-Guaraldi
  • A. Burkovski
Название журнала
  • Vaccine
Том
  • 37
Выпуск
  • 23
Страницы
  • 3061-3070
Ключевые слова
  • bacterial protein; diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b vaccine; diphtheria toxin; diphtheria vaccine; formaldehyde; bacterial protein; bacterium antibody; cross linking reagent; diphtheria toxoid; pertussis vaccine; adult; antibody production; Article; bacterial growth; bioinformatics; clinical article; controlled study; Corynebacterium diphtheriae; Corynebacterium ulcerans; cross linking; diphtheria; hematopoietic stem cell transplantation; human; immunogenicity; mass spectrometry; nonhuman; prediction; priority journal; proteomics; revaccination; Western blotting; chemistry; Corynebacterium; Corynebacterium diphtheriae; cytoplasm; diphtheria; Europe; immunology; proteomics; vaccination; Antibodies, Bacterial; Bacterial Proteins; Corynebacterium; Corynebacterium diphtheriae; Cross-Linking Reagents; Cytoplasm; Diphtheria; Diphtheria Toxoid; Europe; Formaldehyde; Humans; Mass Spectrometry; Pertussis Vaccine; Proteomics; Vaccination
Издатель
  • Elsevier Ltd
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus